NICE approves life-changing gene therapy for treating spinal muscular atrophy
A new and potentially curative one-off gene therapy for babies with the rare genetic disorder spinal muscular atrophy (SMA) is...
Read MoreNuVasive and the International Spine Study Group Foundation announce expanded long-term partnership with initiation of additional clinical studies
NuVasive, a spine technology innovation company, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, and the International...
Read MorePatients should receive COVID-19 vaccine before surgery to reduce risk of postoperative death
Patients waiting for elective surgery should get COVID-19 vaccines ahead of the general population – potentially helping to avoid thousands...
Read MoreATHLET® – Cervical vertebral body replacement
Promotional feature ATHLET® is a vertebral body replacement implant used for stabilisation and reconstruction of the cervical spine (C3 –...
Read MoreMainstay Medical announces commercial launch of ReActiv8 in Australia
Mainstay Medical Holdings recently announced the commercial launch in Australia of ReActiv8®, its implantable neurostimulation system to treat chronic low back...
Read MoreCovid positive patients should delay surgery to reduce death risk
Surgery should be delayed for seven weeks after a patient tests positive for COVID-19 – as operations taking place up...
Read MoreMedTech start-up, Axis Spine Technologies, completes £2.2m funding round led by ACF Investors
Axis Spine Technologies Ltd (AST) has raised £2.2m in a funding round led by ACF Investors, with follow-on investment from...
Read MoreNew potential for functional recovery after spinal cord injury
Researchers at Indiana University School of Medicine have successfully reprogrammed a glial cell type in the central nervous system into...
Read More